Xuyi Liu

2.8k total citations · 2 hit papers
58 papers, 2.3k citations indexed

About

Xuyi Liu is a scholar working on Renewable Energy, Sustainability and the Environment, Oncology and Economics and Econometrics. According to data from OpenAlex, Xuyi Liu has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Renewable Energy, Sustainability and the Environment, 17 papers in Oncology and 16 papers in Economics and Econometrics. Recurrent topics in Xuyi Liu's work include Energy, Environment, Economic Growth (16 papers), Energy, Environment, and Transportation Policies (14 papers) and Environmental Impact and Sustainability (10 papers). Xuyi Liu is often cited by papers focused on Energy, Environment, Economic Growth (16 papers), Energy, Environment, and Transportation Policies (14 papers) and Environmental Impact and Sustainability (10 papers). Xuyi Liu collaborates with scholars based in China, South Korea and United States. Xuyi Liu's co-authors include Junghan Bae, Shun Zhang, Hao Kong, Tongtong An, Jie Wang, Hua Bai, Xuewu Liang, H. J. Lü, Yitian Ma and Yan Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Cleaner Production.

In The Last Decade

Xuyi Liu

56 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Urbanization and industrialization impact of CO2 emissions in China

2017 495 citations Xuyi Liu et al. profile →
The impact of renewable energy and agriculture on carbon dioxide emissions: Investigating the environmental Kuznets curve in four selected ASEAN countries

2017 470 citations Xuyi Liu, Shun Zhang et al. profile →

Peers

Countries citing papers authored by Xuyi Liu

Since Specialization

Citations

This map shows the geographic impact of Xuyi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyi Liu more than expected).

Fields of papers citing papers by Xuyi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuyi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyi Liu. The network helps show where Xuyi Liu may publish in the future.

Co-authorship network of co-authors of Xuyi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuyi Liu. A scholar is included among the top collaborators of Xuyi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuyi Liu. Xuyi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Better e-commerce less carbon emissions in China? 2025 ·Energy ·Xuyi Liu, (unknown), Shun Zhang	2
2	Nanozyme with dual enzyme activity mediating cascade catalytic therapy synergize multiple functions for antitumor therapy 2025 ·Chinese Chemical Letters ·Dou Zhang, Xinyi Cai, Yimin Li, Yong Liu, (unknown), (unknown), Xuyi Liu, Yuta Nishina, Yajuan Zou, Jianbo Sun, Shujing Liang, Daxiang Cui, Ting Yin	0
3	Manganese-based nanoenzymes: from catalytic chemistry to design principle and antitumor/antibacterial therapy 2025 ·Nanoscale ·(unknown), (unknown), Xinyi Cai, Dou Zhang, Xuyi Liu, Jianbo Sun, Muhammad Rizwan Younis, Daxiang Cui, Ting Yin	4
4	Double plasmonic effect and step-like charge transport channel synergistically enhance bulk and surface charge separation efficiency of Au/Cu2O-modified TiO2 photoanode for efficient photoelectrochemical water splitting 2024 ·Fuel ·(unknown), Xuyi Liu, Meng Jiang, Hui Yao, (unknown), Tianyu Qin, (unknown), Shijie Wang, Xiaoxia Bai, Wenzhong Wang, Yujie Liang	2
5	Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses 2024 ·Journal of Ovarian Research ·(unknown), (unknown), Xuyi Liu, Jun Zhang, (unknown)	1
6	3D printing of poly(ethyleneimine)-functionalized Mg-Al mixed metal oxide monoliths for direct air capture of CO2 2024 ·Journal of Energy Chemistry ·(unknown), Zhuozhen Gan, Bingyao Ge, Xuyi Liu, Chunping Chen, Dermot O’Hare, Xuancan Zhu	14
7	A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy 2024 ·International Journal of Nanomedicine ·(unknown), Xuyi Liu, Li Xiong, (unknown), (unknown), (unknown), (unknown), Yuyu Liu, Jianbo Sun, Daxiang Cui, (unknown), Ting Yin	4
8	Tracking China’s CO2 emissions using Kaya-LMDI for the period 1991–2022 2024 ·Gondwana Research ·Shun Zhang, Xuyi Liu	22
9	The glycoside hydrolase gene family profile and microbial function of Debaryomyces hansenii Y4 during South-road dark tea fermentation 2023 ·Frontiers in Microbiology ·Yao Zou, (unknown), (unknown), Xuyi Liu, Xian Li, (unknown), Qian Tang, Wei Xu	2
10	Comparing the environmental impacts of nuclear and renewable energy in top 10 nuclear-generating countries: evidence from STIRPAT model 2022 ·Environmental Science and Pollution Research ·Shun Zhang, Jiawen Liu, Xuyi Liu	7
11	I₂-induced cascade cyclization and dearomatization of indoles for the highly efficient synthesis of iodinated and vinylic spiroindolenines 2021 ·Green Chemistry ·Xiaohui Wei, Xuewu Liang, (unknown), Qi Liu, Xuyi Liu, Yu Zhou, Hong Liu	8
12	Can urbanization, renewable energy, and economic growth make environment more eco-friendly in Northeast Asia? 2021 ·Renewable Energy ·Xuyi Liu, Hao Kong, Shun Zhang	57
13	Aggregate and disaggregate analysis on energy consumption and economic growth nexus in China 2018 ·Environmental Science and Pollution Research ·Xuyi Liu	24
14	Down‐regulation of c‐fos by shRNA sensitizes adriamycin‐resistant MCF‐7/ADR cells to chemotherapeutic agents via P‐glycoprotein inhibition and apoptosis augmentation 2013 ·Journal of Cellular Biochemistry ·Ruizan Shi, Hongwei Peng, Xiangfei Yuan, Xiuli Zhang, Yanjun Zhang, Dongmei Fan, Xuyi Liu, Dongsheng Xiong	33
15	Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non‐small cell lung cancer when treated with EGFR‐tyrosine kinase inhibitors 2013 ·Thoracic Cancer ·Zhigang Wei, Tongtong An, Zhijie Wang, Ke‐Neng Chen, Hua Bai, Guangying Zhu, Jianchun Duan, Meina Wu, Lu Yang, Minglei Zhuo, Yuyan Wang, Xuyi Liu, Jie Wang	21
16	[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China]. 2012 ·SHILAP Revista de lepidopterología ·Longyun Li, Wei Zhong, Meilin Liao, Li Chen, Baohui Han, Zhongzhen Guan, Shiying Yu, Xuyi Liu, Yi‐Long Wu, Guoliang Jiang, Jianming Xu, Jia Chen, (unknown), Rongcheng Luo, Weimin Li, Nong Xu, (unknown), Mengzhao Wang	5
17	Phase III, randomized, open‐label, first‐line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non‐small‐cell lung cancer: evaluation of patients recruited from mainland China 2012 ·Asia-Pacific Journal of Clinical Oncology ·Yi‐Long Wu, (unknown), Baohui Han, Xuyi Liu, Li Zhang, (unknown), Meilin Liao, Tony Mok, Haiyi Jiang, Emma Duffield, Masahiro Fukuoka	38
18	Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer 2009 ·Medical Oncology ·Xin Wang, Jun Zhao, Lu Yang, Li Mao, Tongtong An, Hua Bai, Shuhang Wang, Xuyi Liu, Guoshuang Feng, Jie Wang	39
19	EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer 2009 ·Lung Cancer ·Meina Wu, Jun Zhao, Sonya Wei Song, Minglei Zhuo, Xin Wang, Hua Bai, Shuhang Wang, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Xuyi Liu, (unknown), Jie Wang	47
20	The results of treatment in 100 patients with limited-stage small cell lung cancer 1993 ·Cancer ·Xuyi Liu, Xiaokui Li, (unknown), Qingqi Li, Xueyi Wang, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact